Skip to main content

Table 3 Comparisons between intranasal dexmedetomidine and nitrous oxide. Patient and parent questionnaires and ED physician’s opinion are presented in this table. Continuous variables are presented using medians and IQRs. Categorical variables are presented using counts and percentages

From: A randomized clinical trial of intranasal dexmedetomidine versus inhaled nitrous oxide for procedural sedation and analgesia in children

 

Intranasal dexmedetomidine

50% Nitrous oxide

p-value

 

Missing (n)

 

Missing (n)

FPS-R by patient

5.5 (2–8)

8

4 (2–6)

15

0.048

FPS-R by parent

6 (2–8)

1

3 (1–7)

0

0.007

Same method acceptable in future /patient

52 (82.5%)

12

59 (88.1%)

7

0.46

Same method acceptable in future /parent

65 (91.5%)

3

70 (94.6%)

0

0.53

Parental satisfaction with the general management

 

1

 

1

 

1 = Not at all satisfied

0

 

0

 

0.094

2 = Not satisfied

3 (4.1%)

 

0

 

3 = Neutral

6 (8.2%)

 

4 (5.5%)

 

4 = Satisfied

19 (26.0%)

 

12 (16.4%)

 

5 = Very satisfied

45 (61.6%)

 

57 (78.1%)

 

Feasibility by ED physician

 

0

 

0

 

1 = Very easy

42 (56.8%)

 

44 (59.5%)

 

0.66

2 = Easy

16 (21.6%)

 

19 (25.7%)

 

3 = Neutral

10 (13.5%)

 

9 (12.2%)

 

4 = Difficult

4 (5.4%)

 

2 (2.7%)

 

5 = Very difficult

2 (2.7%)

 

0

 
  1. Abbreviations FPS-R = Faces Pain Scale revised, ED = Emergency Department